 |
| |||
| basis for evaluation (Yeldar Azanbayev) | |||
| |||
| primary endpoint (tll) | |||
| основные критерии оценки: 2 phrases in 2 subjects |
| Clinical trial | 1 |
| Medical | 1 |
|
| |||
| basis for evaluation (Yeldar Azanbayev) | |||
| |||
| primary endpoint (tll) | |||
| основные критерии оценки: 2 phrases in 2 subjects |
| Clinical trial | 1 |
| Medical | 1 |